NR

Nibha Rani

Active Director Director DIN 05258848
DIN 05258848 First appointment May 2012 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2012
Shareholding value •••• Premium profile

About Nibha Rani

Data last updated:

Nibha Rani is a Director at Globocare Pharmaceuticals Private Limited (since 2012). The company operates in Chemicals. Globocare Pharmaceuticals Private Limited reported revenue of ₹44.3 Lakh (FY 2023).

DIN 05258848
Primary Designation Director
Industry Chemicals
First Appointment 30 May 2012
Oldest Company Age 14 yrs
Largest company Globocare Pharmaceuticals Private Limited · ₹44.3 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 May 20122012₹44.3 Lakh (FY 2023)Active

Board colleagues of Nibha Rani

NameDINCompanyDesignation
Reena Singh08346257Globocare Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Globocare Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nibha Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nibha Rani

Nibha Rani currently holds 1 directorship: Globocare Pharmaceuticals Private Limited (Director, since 30 May 2012, revenue ₹44.3 Lakh (FY 2023)).

Nibha Rani was first appointed on 30 May 2012 as Director at Globocare Pharmaceuticals Private Limited.

The current boards of Nibha Rani's companies include Reena Singh (Globocare Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available